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breathing spontaneously during the whole procedure.
Anesthesia was maintained with isoflurane and fentanyl.
Routine tracheostomy was difficult to perform in this
case because of the huge size of the swelling, so mediastinal
approach for tracheostomy was used. Once mediastinal
tracheostomy was completed, endotracheal tube was pulled
out after end tidal carbon dioxide confirmation via
tracheostomy tube of size 9 french. She was awakened at
the end of procedure. She remained stable postoperatively.
Discussion
Airway assessment of patients with difficult airway
includes history, physical examination and imaging studies
although it has been reported that the ease of intubation was
unrelated to the extent of abnormality seen on imaging
studies of the neck.3 Patient should be kept spontaneously
breathing whenever there is concern that the airway will be
compromised on anaesthesia induction. The technique of
inhalational induction for this has regained acceptability
following the introduction of sevoflurane. 
Tracheostomy under local anaesthetic was an option
considered in this case. A tracheostomy tray was open and
ready in the event of any problem arising during fibreoptic
intubation, but this could have been difficult because of her
huge thyroid swelling over trachea and the indistinct
anatomical landmarks.4 Retrograde intubation or
introduction of a transtracheal cannula would also have been
difficult for the same reasons. Other options would be blind
nasal intubation in spontaneously breathing patient but with
the risk of bleeding.5 As presence of blood in oropharynx can
cause laryngospasm, hence fibreoptic bronchoscopy would
have been difficult. The only viable option left was
fibreoptic intubation,6 which the patient tolerated well.
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Abstract
We report two otherwise healthy patients with no
prior history of thyroid cancer, who presented to us with a
solitary scalp lump. Neuroimaging of both patients showed
osteolytic lesions involving the cranium which were
subjected to complete excision biopsy and cranioplasty.
Histopathological examination revealed metastases from
well differentiated follicular thyroid carcinoma (FTC).
Subsequent workup confirmed occult primary carcinoma of
the thyroid gland in both patients. 
Introduction
Follicular thyroid carcinomas (FTC) are subtypes of
thyroid cancers which show high propensity for blood borne
metastases. These are slow growing tumours and are
associated with a favourable prognosis except when they
present with metastasis, which is usually to lungs or
bones.1,2 Metastatic tumours to the skull are most often
from lung, breast and prostate malignancies and rarely from
thyroid cancers. In a series of 473 patients with thyroid
cancers, Nagamine et al reported skull metastases in only
2.5 to 5.8% of cases.3 In almost all the reported cases of
follicular thyroid carcinoma metastasizing to the skull,
metastases occurred long after the diagnosis and institution
of treatment for primary cancer, and there have been only a
handful of cases in the literature in which solitary skull
metastasis was the presenting feature of  an occult FTC.4-6
We report 2 such patients treated at our institution within the
last 2 years.
Case 1
A 62 years old female presented to the neurosurgical
outpatient clinic with complaints of enlarging swelling of
the vertex with mild diffuse headache since one year. About
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two years ago, the patient was diagnosed of having
hyperthyroidism secondary to toxic goiter with no clinical
or ultrasonographic evidence of nodularity. The Technitium-
99m scintigraphy done at that time showed diffuse
radiouptake by the gland. She was prescribed anti-thyroid
medication, Carbimazole, on which her thyroid status
remained well controlled. On presentation, she was
clinically euthyroid with mild diffusely enlarged thyroid
gland. Examination revealed a firm, well circumscribed
lump at the vertex involving bilateral frontal and parietal
bones and intact overlying skin. Neurological examination
was unremarkable. Routine blood tests and thyroid function
tests were also within normal limits. Skull X-ray and
contrast enhanced computerized tomography (CT)
demonstrated a 4 x 4 x 3 cm lytic lesion of the vertex
destroying the outer and inner table of the bilateral frontal
and parietal bones, extending extradurally under the scalp. 
Patient was planned for excision biopsy of the
lesion. Intra-operatively, we found a firm, vascular lesion
involving the skull and the underlying dura. Tumour was
also invading the superior sagittal sinus. The entire tumour
along with the involved dura was removed, and the portion
overlying the sinus was gently peeled away. Artificial dura
was used to cover the dural defect and acrylic was used for
the bony defect. Patient made an uneventful recovery.
Histopathology revealed metastasis from well differentiated
follicular carcinoma of the thyroid. H&E stained sections
showed cuboidal thyroid follicular tumour cells having
pleomorphic nuclei, arranged in closely packed follicles
with evidence of invasion into blood vessels and dura mater.
Cells showed positive staining for thyroglobulin and
epithelial membrane antigen. Later workup included thyroid
ultrasonography which revealed a 1.3 x 1.1 cm nodule in
left lobe that was cold on Technitium-99m scintigraphy with
no uptake elsewhere in the body. The patient underwent a
total thyroidectomy 30 days later and was started on
thyroxine replacement. A postoperative MRI was done after
three months that showed no residual or recurrent tumour
and she is symptom free at 22 months follow up.
Case 2
A 65 years old female from rural part of Northern
Pakistan, with no known co-morbids, presented to our
outpatient clinic with a right frontal lump which she
incidentally noticed five years back. The lump had been
painless and was slowly but gradually increasing in size,
thus the delay in presentation. She was otherwise healthy
with no significant past medical or surgical history. On
presentation, she was clinically euthyroid with normal
general physical, systemic and neurological examination.
Local examination revealed a 6 x 7 x 2 cm right fronto-
parietal soft, fluctuant lump with well-defined margins.
Routine blood tests and thyroid function tests were normal.
Skull X-ray showed a large right fronto-parietal lytic lesion
with some focal calcifications in the soft component of the
lesion. Contrast enhanced computed tomography (CT)
demonstrated a 6.0 x 2.5 cm right frontal bone mass
completely destroying the outer table and involving the
inner table of the bone, with a subgaleal soft tissue
component showing intense contrast uptake. (Fig 1)
Patient was planned for excision biopsy and a right
frontal craniotomy was performed. Intra-operatively, we
found a firm, vascular tumour which was totally resected
along with surrounding bone and the skull was subsequently
reconstructed with acrylic. (Fig 2) H&E stained sections of
the lesion demonstrated a neoplastic lesion comprising of
follicles of varying sizes, filled with colloid and surrounded
by cuboidal cells with pleomorphic nuclei and low grade
mitotic activity. The cells showed positive
immunohistochemical staining for thyroglobulin,
cytokeratin 7 and cytokeratin CAM. The patient recovered
well after surgery and post-operative CT showed no residual
tumour. Her subsequent work up revealed an occult primary
in the right lobe of thyroid for which she was advised
further investigations which she refused and has since been
lost to follow up.
Discussion
Thyroid cancers account for about 0.5 % of all
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Fig 1: Preoperative CT scan, bone window showing an osteolytic lesion in the right
frontoparietal region with overlying enhancing soft tissue component.
cancers in men and 1.5 % of all cancers in women.7 In
Pakistan, thyroid cancer is responsible for about 1.2 % cases
of all malignant tumours, with patients usually presenting
with neck mass.8,9 Follicular thyroid carcinomas (FTC) are
subtypes of thyroid cancers which are slow growing
tumours and are associated with a favourable prognosis
except when they present with distant metastasis.1 Lung and
bone are the two most favoured sites of metastases.2 Bone
metastases from FTC tend to be multiple and more often to
the ribs, vertebrae and sternum.10 Skull is a rare site for
metastases which when occur, are most commonly located
in the occipital region presenting as a soft, painless lump.3,6
These lesions are osteolytic on skull X-ray and CT scan and
highly vascular on angiographic assessment.3,4 The largest
case series of skull metastases from all types of thyroid
cancers consists of 12 cases reported by Negamine et al.3 In
this series, mean time from the diagnosis of thyroid tumour
until discovery of skull metastasis was 23.3 years.
Prognosis in case of metastasis is generally poor and the 10
year survival with bone metastases from differentiated
thyroid cancers is reported to be 27%.2 However, the
reported mean survival in patients who present with skull
metastases in the case series by Negamine et al is just 4.5
years suggesting that these subset of patients tend to do even
worse.3
Both our patients were female in their sixties and
presented with a solitary skull lump that turned out to be
metastatic follicular thyroid carcinoma on excision biopsy
and only then were they worked up to find the occult
primary lesion. Although the first patient was a known case
of toxic goiter and was being treated medically, the other
had no symptoms and signs of thyroid disease. Neither of
the two patients had palpable thyroid nodules or cervical
lymph nodes as might be expected in patients with advanced
follicular thyroid cancers. The sole complaint of a
disfiguring scalp lump makes these two cases very unusual.
Interestingly, the first patient also had mild to moderate pain
around the swelling that could be due to meningeal invasion
by the tumor, although she did not have meningism,
signifying lack of inflammation around the tumor that was
also confirmed later on histopathology. The first case also
requires special mentioning as there is no report to date, of
a FTC presenting as a solitary metastasis to the skull which
is locally advanced showing frank invasion of the dura and
underlying superior sagittal sinus. 
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Fig 2: Post-cranioplasty CT scan, bone window showing no evidence of residual tumor.
